Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ELVN-001 |
Synonyms | |
Therapy Description |
ELVN-001 is an ATP-competitive tyrosine kinase inhibitor with selective activity against ABL1, which potentially leads to decreased tumor cell proliferation and antitumor activity (Blood (2022) 140 (Supplement 1): 3095-3096). |